Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 3rd September 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Flea treatment recalled over labelling error
The VMD has issued a product defect recall alert for a single batch of Johnson's 4Fleas 80mg Spot-on solution for Cats.
Recall concerns single batch of Johnson’s 4Fleas 80mg Spot-on Solution for Cats.

The Veterinary Medicines Directorate (VMD) has issued a product defect recall alert for Johnson’s 4Fleas 80mg Spot-on Solution for Cats, manufactured by Johnson’s Veterinary Products Ltd.

In a press release, the VMD reports that the treatment was being recalled owing to a labelling error.

On the leaflet provided in the box, it states: 'For the prevention and treatment and prevention of flea (Ctenocephalides felis) infestations on cats of less than 4 kg bodyweight.'

However, the leaflet should state: 'For the prevention and treatment and prevention of flea (Ctenocephalides felis) infestations on cats greater or equal to 4 kg bodyweight.'

The recall affects only a single batch – DO41 Johnson's 4Fleas Large Cat 6X2X0.8ml – KP0F3U7

The VMD writes: 'Johnson’s Veterinary Products Ltd is contacting wholesale dealers to examine inventory immediately and quarantine products subject to this recall. This issue only applies to the batch listed above. Any other batches of Johnson’s 4Fleas 80mg Spot-on Solution for Cats are not impacted and may continue to be distributed.'

For further details about the recall contact Grant Exall, quality assurance/WQP, email: Grantexall@johnsons-vet.com, or Nick Franks, sales director, email Nickfranks@johnsons-vet.com, or Tel: 0121 378 1684.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.